| Literature DB >> 30719437 |
Marco Tallarico1, Joseph Fiorellini2, Yasushi Nakajima3,4, Yuki Omori3,4, Iida Takahisa3,4, Luigi Canullo1.
Abstract
PURPOSE: Instead of original abutments, compatible abutments are often selected for financial reasons. The present study aimed to evaluate mechanical outcomes, microleakage, and marginal accuracy at the implant-abutment interface of original versus nonoriginal implant abutments. STUDY SELECTION: Search strategy encompassed literature from 1967 up to March 2017 to identify relevant studies meeting the inclusion criteria. The following electronic databases were consulted: PubMed database of the U.S. National Library of Medicine, Embase (Excerpta Medica dataBASE), and the Grey Literature Database (New York Academy of Medicine Grey Literature Report). Quality assessment of the full-text articles selected was performed. Abutments were classified in original (produced by the same implant manufacturer), nonoriginal certified (produced by a third-party milling center, certified by implant companies), and nonoriginal compatible (produced by a third-party milling center for similar connections).Entities:
Mesh:
Substances:
Year: 2018 PMID: 30719437 PMCID: PMC6334323 DOI: 10.1155/2018/2958982
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Main data of the included studies.
| Authors | IAI | Abutments | Test | Control |
|---|---|---|---|---|
| Alonso-Pérez et al. 2017a | IH | 45 | Stock (n=15) | Compatible stock (n=30) |
|
| ||||
| Alonso-Pérez et al. 2017b | IH | 26 | Stock (n=13) | Certified CAD/CAM (n=13) |
|
| ||||
| da Cunha et al. 2012 | MT | 24 | CAD/CAM (n=8) | Compatible CAD/CAM (n=16) |
|
| ||||
| Berberi et al. 2014 | MT | 28 | Stock (n=7) | Compatible stock (n=21) |
|
| ||||
| Berberi et al. 2016 | MT | 15 | Stock (n=5) | Compatible stock (n=10) |
|
| ||||
| Cashman et al. 2011 | EH | 40 | Stock (n=20) | Compatible Stock (n=20) |
|
| ||||
| Gigandet et al. 2014 | MT,I3L | 60 | CAD/CAM (n=36) | Compatible CAD/CAM (n=24) |
|
| ||||
| Hamilton et al. 2013 | MT,EH,I3L | 11 | Stock (n=6) | Compatible CAD/CAM (n=4) |
|
| ||||
| Kim et al. 2013 | I3L | 60 | CAD/CAM (n=20) | Certified CAD/CAM (n=40) |
|
| ||||
| Kim et al. 2013 | MT | 21 | Stock (n=7) | Certified CAD/CAM (n=7) |
|
| ||||
| Lang et al. 2003 | EH | 30 | CAD/CAM (n=6) | Compatible CAD/CAM (n=24) |
|
| ||||
| Leutert at al. 2012 | MT | 84 | CAD/CAM (n=4) | Certified CAD/CAM (n=80) |
|
| ||||
| Paek et al. 2016 | MT | 6 | Stock (n=3) | Certified CAD/CAM (n=3) |
|
| ||||
| Park et al. 2017 | MT | 28 | Stock (n=7) | Compatible stock (n=21) |
|
| ||||
| Sola-ruitz et al. 2013 | EH | 150 | Stock (n=25) | Compatible stock (n=125) |
|
| ||||
| Yilmaz et al. 2015 | IH | 25 | CAD/CAM (n=5) | Compatible stock (n=10) |
|
| ||||
| Total | 653 | 188 (Stock 108, CAD/CAM 80) | 465 (Certified 155, Compatible 310) | |
Legend: IH: internal hexagon; MT: morse tapered; EH: external hexagon; I3L: internal tri-channel; IAI: implant-abutment interface.
Figure 1Flow diagram of the search strategy for study selection based on PRISMA.
Reporting quality of all included studies.
| Authors | Trial design | How sample size was determined | Random allocation sequence | Mechanism used to implement the random allocation sequence | Method for blinding outcome assessors | ISO 14801 | Risk of bias |
|---|---|---|---|---|---|---|---|
| Alonso-Pérez et al. 2017a | YES | NR | YES | NR | NR | NR | High |
|
| |||||||
| Alonso-Pérez et al. 2017b | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| da Cunha et al. 2012 | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| Berberi et al. 2014 | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| Berberi et al. 2016 | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| Cashman et al. 2011 | YES | NR | YES | NR | NR | YES | Moderate |
|
| |||||||
| Gigandet et al. 2014 | YES | NR | NR | NR | NR | YES | High |
|
| |||||||
| Hamilton et al. 2013 | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| Kim et al. 2013 | YES | NR | YES | NR | NR | YES | Moderate |
|
| |||||||
| Kim et al. 2013 | YES | NR | NR | NR | NR | YES | High |
|
| |||||||
| Lang et al. 2003 | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| Leutert at al. 2012 | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| Paek et al. 2016 | YES | NR | NR | NR | NR | YES | High |
|
| |||||||
| Park et al. 2017 | YES | NR | NR | NR | NR | YES | High |
|
| |||||||
| Sola-ruitz et al. 2013 | YES | NR | NR | NR | NR | NR | High |
|
| |||||||
| Yilmaz et al. 2015 | YES | NR | NR | NR | NR | NR | High |